EMIT II Plus 6-Acetylmorphine Assay

Accurately screen for heroin use

Maintain a high level of integrity in your drug testing program, with the addition of the Emit® II Plus 6-Acetylmorphine Assay to your current offering.

Over the past decade, the number of heroin confiscations has more than doubled.1 Furthermore, an increasing amount of morphine-type drugs are prescribed as analgesics that can cross-react with traditional opiate assays.

Can a rapid screen differentiate heroin use from prescribed or ‘over-the-counter’ medications?

The presence of the heroin metabolite 6-Acetylmorphine (6-AM) in urine specifically confirms the use of heroin. The new EMIT II Plus 6-Acetylmorphine Assay is intended for the qualitative and semi-quantitative determination of 6-AM in human urine, at a cut-off value of 10 ng/mL. This new assay meets the Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines for Federal Workplace Testing.

The EMIT® II Plus 6-Acetylmorphine Assay provides:

High specificity for 6-Acetylmorphine (6-AM)

No cross-reactivity to morphine, morphine metabolites, and common analgesics